Login to Your Account

CEO Chris Viehbacher ousted

Early Wednesday, Sanofi SA's board of directors made the move that most observers had expected in recent days, unanimously unseating Chris Viehbacher as CEO.

more »

Our Habitat for All Things Science
For Ebola victory, scientific advances could help with nonscientific challenges

From a purely scientific standpoint, the news about the Ebola outbreak has been encouraging. New genomic technologies enable unprecedented surveillance of the virus. There are drugs and vaccines in clinical trials. And in response to the urgency of the crisis, both drugmakers and regulatory agencies are making efforts to expedite the process of getting weapons against Ebola through the regulatory process and into the field, where they are needed. (See BioWorld Today, Oct. 22, 2014.)



Partners in Focus